Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research from $1 million to $4 million; establishes dedicated, non-lapsing Cancer Research Fund.
This bill increases annual funding for the New Jersey Commission on Cancer Research (NJCCR) from $1 million to $4 million by redirecting cigarette and tobacco tax revenues into a dedicated fund. It establishes a non-lapsing Cancer Research Fund within the Department of the Treasury, ensuring these funds remain available year after year without requiring annual reappropriation. The fund will be used exclusively to provide grants for cancer research projects approved by the NJCCR, including studies on cancer causes, prevention, treatment, and palliation. The State Treasurer will manage the fund, including investing the money and disbursing funds upon written approval from the NJCCR chairperson.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024
Last action Jan 9, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about A 3197
Scope: NJ
Hi! I can help you understand A 3197. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline